Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. | Front Cell Dev Biol | 2022 | 36544907 | PubTator, text mining | PubMed |
| Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. | Front Mol Biosci | 2022 | 36533073 | PubTator, text mining | PubMed |
| Gene expression analysis in endometriosis: Immunopathology insights, transcription factors and therapeutic targets. | Front Immunol | 2022 | 36532015 | PubTator, text mining | PubMed |
Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis. | BMC Pregnancy Childbirth | 2022 | 36528566 | PubTator, text mining | PubMed |
| An intravenous anesthetic drug-propofol, influences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: A narrative literature review. | Front Pharmacol | 2022 | 36506511 | PubTator, text mining | PubMed |
| Circ_0007534 as new emerging target in cancer: Biological functions and molecular interactions. | Front Oncol | 2022 | 36505874 | PubTator, text mining | PubMed |
| Decidualization of human endometrial stromal cells requires steroid receptor coactivator-3. | Front Reprod Health | 2022 | 36505394 | PubTator, text mining | PubMed |
| Electrostatic anti-CD33-antibody-protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia. | J Hematol Oncol | 2022 | 36457063 | PubTator, text mining | PubMed |
| Biomechanical Forces Determine Fibroid Stem Cell Transformation and the Receptivity Status of the Endometrium: A Critical Appraisal. | Int J Mol Sci | 2022 | 36430682 | PubTator, text mining | PubMed |
| Circulating Long Non-Coding RNAs Could Be the Potential Prognostic Biomarker for Liquid Biopsy for the Clinical Management of Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36428681 | PubTator, text mining | PubMed |
| DNA5mC Regulator-Mediated Molecular Clusters and Tumor Microenvironment Signatures in Glioblastoma. | Front Cell Dev Biol | 2022 | 36425533 | PubTator, text mining | PubMed |
| Current advances in the selection of adjuvant radiotherapy regimens for keloid. | Front Med (Lausanne) | 2022 | 36425105 | PubTator, text mining | PubMed |
| HOXA11-OS participates in lupus nephritis by targeting miR-124-3p mediating Cyr61 to regulate podocyte autophagy. | Mol Med | 2022 | 36418932 | PubTator, text mining | PubMed |
| LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. | Cell Death Dis | 2022 | 36418856 | PubTator, text mining | PubMed |
| Bi-potential hPSC-derived Müllerian duct-like cells for full-thickness and functional endometrium regeneration. | NPJ Regen Med | 2022 | 36418304 | PubTator, text mining | PubMed |
| Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells. | Evid Based Complement Alternat Med | 2022 | 36408341 | PubTator, text mining | PubMed |
| Knockdown of LINC01279 Suppresses Gastric Cancer Proliferation and Migration by Inhibiting PI3K/Akt/mTOR Signaling Pathway. | J Oncol | 2022 | 36397761 | PubTator, text mining | PubMed |
| Manuscript Title: A 4-miRNAs Serum Panel for Obstructive Sleep Apnea Syndrome Screening. | Nat Sci Sleep | 2022 | 36394070 | PubTator, text mining | PubMed |
| The evolution and polymorphism of mono-amino acid repeats in androgen receptor and their regulatory role in health and disease. | Front Med (Lausanne) | 2022 | 36388907 | PubTator, text mining | PubMed |
| Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells. | J Gastrointest Oncol | 2022 | 36388689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=15